Shakerinasab Nasrin, Bejeshk Mohammad Abbas, Pourghadamyari Hossein, Najafipour Hamid, Eftekhari Mahdieh, Mottaghipisheh Javad, Omidifar Navid, Azizi Mahdokht, Rajizadeh Mohammad Amin, Doustimotlagh Amir Hossein
Student Research Committee, Yasuj University of Medical Sciences, Yasuj, Iran.
Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
Evid Based Complement Alternat Med. 2022 Jun 21;2022:5319237. doi: 10.1155/2022/5319237. eCollection 2022.
Asthma is known as a disease that causes breathing problems in children and adults and is also associated with chronic inflammation and oxidative stress of the airways. () possesses a wide range of pharmacological properties, particularly anti-inflammation and antioxidant potentials. Thus, this study for the first time was aimed to investigate anti-inflammatory and antioxidative activities of extract () in an ovalbumin-induced rat model of asthma.
Forty-four male Wistar rats were sensitized with ovalbumin (OVA) to induce asthma symptoms. The animals were allocated into five groups: control (C), asthmatic (A), A + (500 mg/kg), (500 mg/kg), and A + dexamethasone (DX, 2.5 mg/kg). After 7 days, blood and tissue samples were taken from the rats. Then, the level of inflammatory markers, oxidative stress parameters, and antioxidant enzymes activity were measured.
The obtained results showed that OVA-sensitive rats significantly increased the levels of pro-inflammatory cytokines IL-1B, TGF-, and SMA- compared to the control group ( < 0.05), while treatment with remarkably reduced the SMA- gene expression compared to the asthma group ( < 0.05). Furthermore, it decreased the expression of IL-1B and TNF- genes, although it was not statistically significant. The level of glutathione peroxidase (GPX) significantly reduced in group compared to the group ( < 0.05), whereas administration significantly increased this marker ( < 0.05). Moreover, attenuated inflammation and alveolar injury in the lungs of OVA-sensitive rat compared to the nontreated group.
Overall, our findings demonstrated that somewhat is able to reduce airway inflammation by reducing inflammatory and increasing GPX activity. Indeed, further experiments investigating the impact of different extract doses are needed to confirm the antioxidant and anti-inflammatory effects of .
哮喘是一种导致儿童和成人呼吸问题的疾病,还与气道的慢性炎症和氧化应激有关。()具有广泛的药理特性,尤其是抗炎和抗氧化潜力。因此,本研究首次旨在研究()提取物在卵清蛋白诱导的大鼠哮喘模型中的抗炎和抗氧化活性。
44只雄性Wistar大鼠用卵清蛋白(OVA)致敏以诱发哮喘症状。将动物分为五组:对照组(C)、哮喘组(A)、A +(500mg/kg)、(500mg/kg)和A +地塞米松(DX,2.5mg/kg)。7天后,从大鼠采集血液和组织样本。然后,测量炎症标志物水平、氧化应激参数和抗氧化酶活性。
所得结果表明,与对照组相比,OVA敏感大鼠促炎细胞因子IL-1B、TGF-和SMA-的水平显著升高(P<0.05),而与哮喘组相比,用()治疗显著降低了SMA-基因表达(P<0.05)。此外,它降低了IL-1B和TNF-基因的表达,尽管无统计学意义。与()组相比,()组谷胱甘肽过氧化物酶(GPX)水平显著降低(P<0.05),而给予()显著增加了该标志物水平(P<0.05)。此外,与未治疗的()组相比,()减轻了OVA敏感大鼠肺部的炎症和肺泡损伤。
总体而言,我们的研究结果表明,()在一定程度上能够通过减少炎症和增加GPX活性来减轻气道炎症。确实,需要进一步实验研究不同提取物剂量的影响,以证实()的抗氧化和抗炎作用。